Skip to content

Comparison of A-PRF vs Bone Wax in Hemostasis, Pain Relief and Healing Following Exodontia

Comparison of A-PRF vs Bone Wax in Hemostasis, Pain Relief and Healing Following Exodontia: A Single-blind Randomised Control Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05744726
Enrollment
129
Registered
2023-02-27
Start date
2023-01-01
Completion date
2023-09-30
Last updated
2023-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Extraction Socket Hemostasis, Post-Extraction Socket Pain Relief, Post-Extraction Socket Healing

Keywords

Platelet Rich Fibrin, Wound Healing, Tooth Extraction, Pain Severity, Bone wax

Brief summary

The goal of this clinical trial is to compare the pain relief and healing effect of A-PRF and Bone-wax in patients having mandibular tooth-extractions. The main question\[s\] it aims to answer are: In the perspective of improvement in pain and healing; * Does A-PRF performs better than control group? * Does Bone-wax performs better than control group? * Healing index and Pain scale score Comparison of A-PRF and Bone-wax; if one is better than the other? Participants will be asked to give resoponse to a post-operative symptom severiety (PoSSe) scale. An investigator will score the patient's extraction for hemostasis and on healing index \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].

Interventions

BIOLOGICALA-PRF

0.5 to 1g of Advance Platelet-Rich Fibrin (A-PRF) clot for each dental socket.

COMBINATION_PRODUCTBone-wax

0.5 to 1g of Bone-wax for each dental socket

Sponsors

Jinnah Postgraduate Medical Centre
CollaboratorOTHER_GOV
Altamash Institute of Dental Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* All patients who need extraction of mandibular posterior teeth * Overall, systemically healthy individuals (Established based on history, i.e., patients who do not take medicine for any systemic condition). * INR within normal range.

Exclusion criteria

* Patients with a diagnosed systemic condition. * Patients who are immunocompromised. * Patients who are unwilling to participate or withdraw from the study. * Patients who fail to report on the seventh and twenty-first post-extraction day. * Patients with physical or mental impairments who need assistance in taking their medications.

Design outcomes

Primary

MeasureTime frameDescription
Pain Relief on VAS21 daysPatients receiving any of the intervention will be evaluated at just before, 3rd, 7th and 21st day of dental extraction on Visual Analogue Scale (VAS).
Extraction socket healing21 daysPatients receiving any of the intervention will be evaluated at 3rd, 7th and 21st day of dental extraction on Healing index by Landry et al.

Secondary

MeasureTime frameDescription
Hemostasis30 minutesThe post-operative bleeding will be evaluated 30 minutes after the placement of the last suture as: * No bleeding * Mild Bleeding: bleeding that stopped spontaneously or with minimal local compression. * Severe Bleeding: bleeding that did not stop with the previous measures and that required local adrenaline or continuous local compression using gauze pack soaked in the corresponding antifibrinolytic agent until the bleeding stops

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026